{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:29:53Z","timestamp":1762079393261},"reference-count":37,"publisher":"Elsevier BV","issue":"33","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.vaccine.2013.05.081","type":"journal-article","created":{"date-parts":[[2013,6,3]],"date-time":"2013-06-03T15:17:47Z","timestamp":1370272667000},"page":"3333-3338","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines"],"prefix":"10.1016","volume":"31","author":[{"given":"Todd G.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Kuzmina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2013.05.081_bib0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00005072-198307000-00006","article-title":"Neurotropism of rabies virus: an in vitro study","volume":"42","author":"Tsiang","year":"1983","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.081_bib0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/13550280490521122","article-title":"Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus","volume":"10","author":"Baloul","year":"2004","journal-title":"J Neurovirol"},{"issue":"22","key":"10.1016\/j.vaccine.2013.05.081_bib0015","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1128\/JVI.01153-10","article-title":"Quantifying antigenic relationships among the lyssaviruses","volume":"84","author":"Horton","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0020","series-title":"Expert Committee on Biological Standardization Thirty-Seventh Report. WHO Technical Report Series","author":"WHO","year":"1987"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0025","series-title":"WHO Expert Committee on Rabies: Eighth Report","author":"WHO","year":"1992"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0030","series-title":"Laboratory techniques in rabies","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2013.05.081_bib0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(88)90185-5","article-title":"NIH test, a problematic method for testing potency of inactivated rabies vaccine","volume":"6","author":"Barth","year":"1988","journal-title":"Vaccine"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2013.05.081_bib0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biologicals.2009.08.002","article-title":"A vaccine measured with a highly variable assay: rabies","volume":"37","author":"Jivapaisarnpong","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-12-387040-7.00016-0","article-title":"Design of future rabies biologics and antiviral drugs","volume":"79","author":"Smith","year":"2011","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0050","first-page":"73","article-title":"Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine","volume":"64","author":"Fitzgerald","year":"1986","journal-title":"Dev Biol Stand"},{"issue":"March (Pt 1)","key":"10.1016\/j.vaccine.2013.05.081_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/0022-1317-59-1-197","article-title":"A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies","volume":"59","author":"Ferguson","year":"1982","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0060","first-page":"207","article-title":"Use of an enzyme immunoassay with protein A for rabies antigen and antibody determination","volume":"46","author":"Atanasiu","year":"1980","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0065","first-page":"267","article-title":"Quantitative determination of rabies antigen by ELISA","volume":"50","author":"van der Marel","year":"1981","journal-title":"Dev Biol Stand"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2013.05.081_bib0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-1157(85)80042-1","article-title":"Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay","volume":"13","author":"Lafon","year":"1985","journal-title":"J Biol Stand"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2013.05.081_bib0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-1157(89)80001-0","article-title":"Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera","volume":"17","author":"Thraenhart","year":"1989","journal-title":"J Biol Stand"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2013.05.081_bib0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1045-1056(90)90037-Z","article-title":"In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody","volume":"18","author":"Perrin","year":"1990","journal-title":"Biologicals"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2013.05.081_bib0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","article-title":"Inactivated rabies vaccine control and release: use of an ELISA method","volume":"31","author":"Fournier-Caruana","year":"2003","journal-title":"Biologicals"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2013.05.081_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","article-title":"A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"34","author":"Nagarajan","year":"2006","journal-title":"Biologicals"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.081_bib0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoproteins with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.081_bib0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-1702(02)00267-8","article-title":"Differential stability and fusion activity of Lyssavirus glycoprotein trimers","volume":"91","author":"Desmezieres","year":"2003","journal-title":"Virus Res"},{"issue":"September (Pt 9)","key":"10.1016\/j.vaccine.2013.05.081_bib0105","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.81063-0","article-title":"Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor","volume":"86","author":"Sissoeff","year":"2005","journal-title":"J Gen Virol"},{"issue":"December (1\u20132)","key":"10.1016\/j.vaccine.2013.05.081_bib0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jviromet.2007.07.015","article-title":"Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate: a novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"146","author":"Mousli","year":"2007","journal-title":"J Virol Methods"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.05.081_bib0115","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00204-10","article-title":"Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein","volume":"17","author":"Nimmagadda","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2013.05.081_bib0120","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis","volume":"79","author":"Marissen","year":"2005","journal-title":"J Virol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2013.05.081_bib0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/zph.12019","article-title":"Multidisciplinary approach to epizootiology and pathogenesis of bat rabies viruses in the United States","volume":"60","author":"Ellison","year":"2013","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0130","series-title":"Laboratory techniques in rabies","first-page":"175","article-title":"Techniques for the purification of rabies virus, its subunits and recombinant products","author":"Dietzschold","year":"1996"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.05.081_bib0135","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull World Health Organ"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.05.081_bib0140","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/JCM.00016-08","article-title":"Lagos bat virus in Kenya","volume":"46","author":"Kuzmin","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.081_bib0145","series-title":"Laboratory techniques in rabies","first-page":"88","article-title":"The fluorescent antibody test","author":"Dean","year":"1996"},{"issue":"November (49\u201350)","key":"10.1016\/j.vaccine.2013.05.081_bib0150","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1016\/j.vaccine.2006.06.078","article-title":"The rabies peripheral challenge test: more accurate determination of vaccine potency","volume":"24","author":"Wunderli","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.05.081_bib0155","doi-asserted-by":"crossref","first-page":"e30659","DOI":"10.1371\/journal.pone.0030659","article-title":"Critical appraisal of four IL-6 immunoassays","volume":"7","author":"Thompson","year":"2012","journal-title":"PLoS ONE"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.05.081_bib0160","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/clinchem\/37.9.1534","article-title":"Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics","volume":"37","author":"Blackburn","year":"1991","journal-title":"Clin Chem"},{"issue":"December (1\u20132)","key":"10.1016\/j.vaccine.2013.05.081_bib0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2007.08.003","article-title":"Comparison of an electrochemiluminescence assay in plate format over a colorimetric ELISA, for the detection of ricin B chain (RCA-B)","volume":"328","author":"Guglielmo-Viret","year":"2007","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.081_bib0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00361329","article-title":"Desorption of porcine parvovirus from aluminum hydroxide adjuvant with subsequent viral immunoassay or hemagglutination assay","volume":"11","author":"Katz","year":"1987","journal-title":"Vet Res Commun"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.05.081_bib0175","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/erv.11.140","article-title":"From brain passage to cell adaptation: the road of human rabies vaccine development","volume":"10","author":"Wu","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2013.05.081_bib0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jim.2009.03.005","article-title":"Development of a direct alhydrogel formulation immunoassay (DAFIA)","volume":"344","author":"Zhu","year":"2009","journal-title":"J Immunol Methods"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2013.05.081_bib0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biologicals.2012.07.005","article-title":"Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward","volume":"40","author":"Stokes","year":"2012","journal-title":"Biologicals"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13006968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13006968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T16:04:02Z","timestamp":1595865842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13006968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":37,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0264410X13006968"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}